Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Good
|
New words:
antitumor, appointment, auditor, beta, book, Canada, CFO, comprised, conclusion, conveyed, deteriorate, enhance, enhanced, fifty, gosrelin, Greg, hand, hearing, hiring, landlord, mammography, milestone, Modulator, optimal, outreach, Panel, percent, PKC, plasma, President, publicly, receipt, recurrence, restructuring, SERM, shutdown, speed, stay, steady, suboptimal, toxicity, variety, Vice, Weaver, wrote
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view